The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
 
Employment - Genentech
Phase I Trial of Intraperitoneal Onyx-015 Adenovirus in Patients with Recurrent Ovarian Cancer.
 
Johanna C. Bendell
Research Funding - Abbott/AbbVie (Inst); Agios (Inst); Apexigen (Inst); ARMO BioSciences (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Onyx (Inst); Sanofi (Inst); Stem CentRx (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Yung-Jue Bang
Consulting or Advisory Role - Samyang
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Chong Kun Dang Pharmaceutical (Inst); Curis (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Macrogenics (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Cheng Ean Chee
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - MPM Capital
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
 
Autumn Jackson McRee
No Relationships to Disclose
 
Laura Q. Chow
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; Genzyme; Merck; Novartis; Pfizer; Seagen
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genzyme (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); VentiRx (Inst)
 
Jayesh Desai
Honoraria - Amgen; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen; Bionomics; Lilly; Novartis; Plexxikon
Research Funding - Bionomics (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche (Inst)
 
Matthew Wongchenko
Employment - Genentech/Roche
Stock and Other Ownership Interests - ARIAD; Genentech/Roche
 
Yibing Yan
Employment - Genentech
 
Bethany Pitcher
Employment - Roche
 
Paul Foster
No Relationships to Disclose
 
Edward Cha
Employment - Genentech
 
William Grossman
No Relationships to Disclose
 
Tae Won Kim
Travel, Accommodations, Expenses - Agios; Genentech; Roche